Elkins Park, Pennsylvania Clinical Trials

A listing of Elkins Park, Pennsylvania clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 118 clinical trials
A Study Evaluating The Safety Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

A study evaluating the safety, preliminary efficacy and pharmacokinetics of ipatasertib in combination with atezolizumab and docetaxel in participants with mCRPC previously treated with second-generation AR (Androgen Receptor)-targeted therapy. The study consists of two parts: [1] Part A: Safety run-in cohort of approximately 12 participants; [2] Part B: Expansion cohort …

gonadotropin releasing hormone
luteinizing hormone
bone lesions
cancer
adenocarcinoma of prostate
Fox Chase Cancer Center
 (2.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +17 other locations
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth (Stage and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Stage 2). Secondary Objectives: To determine the effect of venglustat on the …

antihypertensive therapy
depression
tolvaptan
urine osmolality
ophthalmological examination
Investigational Site Number 8400011
 (8.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +80 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

tamoxifen
estrogen receptor
advanced breast cancer
cancer
ESR1
Investigational Site Number 8400001
 (4.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +125 other locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

tremor
bradykinesia
parkinsonism
dopamine transporter
resting tremor
Abington Neurological Associates Willow Grove
 (5.2 away)
  • 0 views
  • 28 Jun, 2022
  • +125 other locations
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

This is a Phase III, two-arm, randomized, double-blind placebo-controlled study in participants with HER2-positive primary breast cancer who have received preoperative chemotherapy and HER2-directed therapy, including trastuzumab followed by surgery, with a finding of residual invasive disease in the breast and/or axillary lymph nodes.

Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit
 (8.7 away) Contact site
  • 0 views
  • 05 Oct, 2021
  • +301 other locations
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

University of Pennsylvania / Perelman Center for Advanced Medicine
 (8.7 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
scrumsecond sync

This is a randomized, open-label, parallel group study to determine the optimal dose of CART-19 cells (of the two dose levels being assessed (1-5x10xE8 vs. 1-5x10xE7 CART-19 cells). This trial will be conducted in two stages. In Stage 2, the selected dose cohort will be expanded to enroll additional subjects, …

Test site COPD
 (8.7 away) Contact site
  • 0 views
  • 22 Feb, 2023
  • 1 location
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

In spinal cord tumors requiring surgical intervention, the resection difficulty is determined by two significant factors: tumor stiffness and adhesion to surrounding tissue. The stiffness of the tumor dictates the complexity of removal, while strong adhesion presents additional challenges during the surgical procedure. This clinical trial aims to assess the …

Accepts healthy volunteers
khjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvkhjkgj jhghjhj hjkghjgf fgyhdfgh jhfgfvjkjkjkjkj
 (8.8 away) Contact site
  • 0 views
  • 25 Jul, 2023
  • +21 other locations
Test reports v6.12 (DO NOT VISIT)

Test

Abington Neurological Associates Willow Grove
 (5.2 away) Contact site
  • 0 views
  • 02 Mar, 2026
  • +2 other locations
smoke test api load dec 2023 (Test1234)

See protocol section 2 See protocol section 2 See protocol section 2

Hospital of the University of Pennsylvania
 (8.7 away) Contact site
  • 0 views
  • 02 Feb, 2024
  • 1 location